HonCode

Go Back   HER2 Support Group Forums > Articles of Interest
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 05-29-2006, 09:42 AM   #1
R.B.
Senior Member
 
Join Date: Mar 2006
Posts: 1,843
suggests a link between hypothalamic sex steroid receptors, fatty acid metabolism, ..

Tamoxifen mechanisms include acting on the fatty acid synethase pathways.

Women on Tamoxifen may loose weight.

Wider interlinking net works fats diets hormones etc.

"suggests a link between hypothalamic sex steroid receptors, fatty acid metabolism, and feeding behavior."


RB

Diabetes 55:1327-1336, 2006
DOI: 10.2337/db05-1356
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by López, M.
Right arrow Articles by Vidal-Puig, A. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by López, M.
Right arrow Articles by Vidal-Puig, A. J.


Tamoxifen-Induced Anorexia Is Associated With Fatty Acid Synthase Inhibition in the Ventromedial Nucleus of the Hypothalamus and Accumulation of Malonyl-CoA

Miguel López1, Christopher J. Lelliott1, Sulay Tovar2, Wendy Kimber1, RosalÃ*a Gallego3, Sam Virtue1, Margaret Blount1, Maria J. Vázquez2, Nick Finer1, Trevor J. Powles4, Stephen O’Rahilly1, Asish K. Saha5, Carlos Diéguez2, and Antonio J. Vidal-Puig1

1 Department of Clinical Biochemistry, University of Cambridge, Addenbrooke’s Hospital, Cambridge, U.K
2 Department of Physiology, School of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain
3 Department of Morphological Sciences, School of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain
4 Parkside Oncology Clinic, London, U.K
5 Diabetes Research Unit, EBRC-827, Boston Medical Centre, Boston, Massachusetts

Address correspondence and reprint requests to Antonio J. Vidal-Puig, PhD, MD, Department of Clinical Biochemistry, University of Cambridge, Addenbrooke’s Hospital, Hills Road Cambridge, CB2 2QR, U.K. E-mail: ajv22@cam.ac.uk

ACC, acetyl-CoA carboxylase; AMPK, AMP-activated protein kinase; ARC, arcuate nucleus of the hypothalamus; CART, cocaine- and amphetamine-regulated transcript; FAS, fatty acid synthase; LHA, lateral hypothalamic area; POMC, proopiomelanocortin; PVN, paraventricular nucleus of the hypothalamus; RMH, Royal Marsden Hospital; TMX, tamoxifen; TOFA, 5-(tetradecyloxy)-2-furoic acid; VMN, ventromedial nucleus of the hypothalamus

Fatty acid metabolism in the hypothalamus has recently been shown to regulate feeding. The selective estrogen receptor modulator tamoxifen (TMX) exerts a potent anorectic effect. Here, we show that the anorectic effect of TMX is associated with the accumulation of malonyl-CoA in the hypothalamus and inhibition of fatty acid synthase (FAS) expression specifically in the ventromedial nucleus of the hypothalamus (VMN). Furthermore, we demonstrate that FAS mRNA expression is physiologically regulated by fasting and refeeding in the VMN but not in other hypothalamic nuclei. Thus, the VMN appears to be the hypothalamic site where regulation of FAS and feeding converge. Supporting the potential clinical relevance of these observations, reanalysis of a primary breast cancer prevention study showed that obese women treated with TMX gained significantly less body weight over a 6-year period than obese women given placebo. The finding that TMX can modulate appetite through alterations in FAS expression and malonyl-CoA levels suggests a link between hypothalamic sex steroid receptors, fatty acid metabolism, and feeding behavior.
R.B. is offline   Reply With Quote
Old 05-29-2006, 08:59 PM   #2
al from Canada
Senior Member
 
al from Canada's Avatar
 
Join Date: Jul 2005
Location: Ontario, Canada
Posts: 722
RB,
This sounds interesting as we know the link between adolescent weight, % weight gain in later life and breast cancer. Throw in other risk factors such as family history, breast density, and many others, this may be a treatment option to bring overall risk much lower. Not for all but some may benefit enough to tip the scale.
Al
__________________
Primary care-giver to and advocate for Linda, who passed away April 27, 2006.
al from Canada is offline   Reply With Quote
Old 05-30-2006, 03:45 AM   #3
R.B.
Senior Member
 
Join Date: Mar 2006
Posts: 1,843
Didnt they think about / do some wider trials on the preventative effects of Tamoxifen.

The problem with all these drug interventions is that in the vast majority the seem to come at a cost in side effects - and I am sure we will se more in the longer term.

For me diet has to be the starting point. Fat utilisation, and hormones are linked the question who controls who, and my guess is it will be a multiple way relationship, but that availability of fats and type will play a key part eg anoexia.

RB
R.B. is offline   Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On

Forum Jump


All times are GMT -7. The time now is 04:38 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter